Allogeneic CD20‐targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B‐cell lymphoma models

OBJECTIVES: Autologous chimeric antigen receptor (CAR) αβ T‐cell therapies have demonstrated remarkable antitumor efficacy in patients with haematological malignancies; however, not all eligible cancer patients receive clinical benefit. Emerging strategies to improve patient access and clinical resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishimoto, Kevin P, Barca, Taylor, Azameera, Aruna, Makkouk, Amani, Romero, Jason M, Bai, Lu, Brodey, Mary M, Kennedy‐Wilde, Jackie, Shao, Hui, Papaioannou, Stephanie, Doan, Amy, Masri, Cynthia, Hoang, Ngoc T, Tessman, Hayden, Ramanathan, Vidhya Dhevi, Giner‐Rubio, Ana, Delfino, Frank, Sharma, Kriti, Bray, Kevin, Hoopes, Matthew, Satpayev, Daulet, Sengupta, Ranjita, Herrman, Marissa, Abbot, Stewart E, Aftab, Blake T, An, Zili, Panuganti, Swapna, Hayes, Sandra M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809437/
https://www.ncbi.nlm.nih.gov/pubmed/35136603
http://dx.doi.org/10.1002/cti2.1373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809437/
https://www.ncbi.nlm.nih.gov/pubmed/35136603
http://dx.doi.org/10.1002/cti2.1373

Ejemplares similares